FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

712519008: Daclatasvir (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2015. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3082832019 Daclatasvir (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3082833012 Daclatasvir en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Daclatasvir Is a Substance with Hepatitis C virus protein NS5A inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Daclatasvir Has disposition Hepatitis C virus protein NS5A inhibitor true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing daclatasvir Has active ingredient True Daclatasvir Inferred relationship Existential restriction modifier 1
Product containing daclatasvir in oral dose form (medicinal product form) Has active ingredient True Daclatasvir Inferred relationship Existential restriction modifier 1
Daclatasvir Has active ingredient True Daclatasvir Inferred relationship Existential restriction modifier 1
Product containing only daclatasvir in oral dose form (medicinal product form) Has active ingredient True Daclatasvir Inferred relationship Existential restriction modifier 1
Daclatasvir dihydrochloride Is modification of True Daclatasvir Inferred relationship Existential restriction modifier
Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 60 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Daclatasvir Inferred relationship Existential restriction modifier 1
Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Daclatasvir Inferred relationship Existential restriction modifier 1
Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 90 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Daclatasvir Inferred relationship Existential restriction modifier 1
Daclatasvir 30mg tablets Has active ingredient False Daclatasvir Inferred relationship Existential restriction modifier
Daclatasvir 60mg tablets Has active ingredient False Daclatasvir Inferred relationship Existential restriction modifier
Daklinza 30mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Daclatasvir Inferred relationship Existential restriction modifier
Daklinza 60mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Daclatasvir Inferred relationship Existential restriction modifier
Daclatasvir dihydrochloride Is a False Daclatasvir Inferred relationship Existential restriction modifier
Daklinza 30mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Daclatasvir Inferred relationship Existential restriction modifier
Daklinza 60mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Daclatasvir Inferred relationship Existential restriction modifier
Daclatasvir 60mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Daclatasvir Inferred relationship Existential restriction modifier
Daclatasvir 30mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Daclatasvir Inferred relationship Existential restriction modifier
Daclatasvir 30mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Daclatasvir Inferred relationship Existential restriction modifier
Daclatasvir 60mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Daclatasvir Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets Has active ingredient False Daclatasvir Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Daclatasvir Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has active ingredient True Daclatasvir Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Daclatasvir Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Daclatasvir Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Daclatasvir Inferred relationship Existential restriction modifier
Daklinza 30mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has basis of strength substance True Daclatasvir Inferred relationship Existential restriction modifier
Daklinza 60mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has basis of strength substance True Daclatasvir Inferred relationship Existential restriction modifier
Daklinza 30mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has basis of strength substance True Daclatasvir Inferred relationship Existential restriction modifier
Daklinza 60mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has basis of strength substance True Daclatasvir Inferred relationship Existential restriction modifier
Daclatasvir 60mg tablets 28 tablet Has basis of strength substance True Daclatasvir Inferred relationship Existential restriction modifier
Daclatasvir 30mg tablets 28 tablet Has basis of strength substance True Daclatasvir Inferred relationship Existential restriction modifier
Daclatasvir 30mg tablets Has basis of strength substance False Daclatasvir Inferred relationship Existential restriction modifier
Daclatasvir 60mg tablets Has basis of strength substance False Daclatasvir Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets Has basis of strength substance False Daclatasvir Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has basis of strength substance True Daclatasvir Inferred relationship Existential restriction modifier
Daclatasvir 90mg tablets 28 tablet Has basis of strength substance True Daclatasvir Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has basis of strength substance True Daclatasvir Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start